ArticleBMC cardiovascular disorders2026
Ebstein's anomaly with life-threatening arrhythmia: an unusual cardiovascular manifestation of Williams syndrome - a case report.
Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWilliams syndrome (WS) is a rare genetic multisystem disorder that often affects the cardiovascular system. However, an association with Ebstein’s anomaly (EA) is extremely uncommon. Previously, only two such cases have been reported. Here, we present a third patient with concurrent WS and EA, manifesting with life-threatening ventricular arrhythmias. CASE PRESENTATION: Our case involves an 11-year-old boy, diagnosed prenatally with EA and 3-months postnatally with WS on the basis of a 7q11.23 deletion. Over the course of follow-up since birth, life-threatening ventricular arrhythmias occurred, originating from a likely fibrosed Purkinje system possibly related to elastin haploinsufficiency. The resulting out-of-hospital cardiac arrest warranted implantation of an implantable cardioverter-defibrillator and antiarrhythmic medication.
conclusionsVentricular arrhythmia and out-of-hospital cardiac arrest constitute an unusual clinical presentation that has not previously been reported in cases with concurrent WS and EA, but may be attributed to elastin haploinsufficiency. This potentially fatal complication underscores the importance of vigilant clinical surveillance in patients with comparable congenital heart defects. Our case report adds further evidence to the limited literature describing congenital cardiac anomalies and associated complications in patients with WS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.